This whitepaper assesses new expectations for clinical evaluations and investigations under the EU MDR including:
- The key differences between MDD and the MDR requirements for clinical evaluations and investigations
- Understanding what Competent Authorities and Notified Bodies are looking for
- Assessing the requirements for legacy devices under the MDR
- Evaluating and rationalising product portfolios
- Key challenges and opportunities with the new clinical requirements
To download simply log in or register for an Informa Connect account, which will give you access to all our exclusive premium content. Have any questions or interested in sponsoring future content? Email firstname.lastname@example.org.